Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA inspectors occasionally show lack of "respect" but not "retaliation," FDAer says.

This article was originally published in The Tan Sheet

Executive Summary

FDA INSPECTION PROGRAM "CULTURE PROBLEMS" DO NOT INCLUDE RETALIATION, FDA Midwest Region Director Burton Love said at a Sept. 20 conference on regulatory compliance sponsored by FDA and the Parenteral Drugs Association in Bethesda, Md. FDA's Office of Regulatory Affairs has been examining the issue of alleged retaliation by FDA inspectors, Love said. Although the agency may have "culture problems," he said, "my observation is that we...probably don't have what is called `retaliation.'" However, he added, "we occasionally have people that don't treat other people with respect."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084337

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel